See more : Bayer Aktiengesellschaft (BAYNN.MX) Income Statement Analysis – Financial Results
Complete financial analysis of Assure Tech (Hangzhou) Co., Ltd. (688075.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Assure Tech (Hangzhou) Co., Ltd., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Compass Group PLC (XGR2.DE) Income Statement Analysis – Financial Results
- Horizon Acquisition Corporation (HZON-WT) Income Statement Analysis – Financial Results
- Nelcast Limited (NELCAST.BO) Income Statement Analysis – Financial Results
- Rentracks CO.,LTD. (6045.T) Income Statement Analysis – Financial Results
- PT Ancora Indonesia Resources Tbk (OKAS.JK) Income Statement Analysis – Financial Results
Assure Tech (Hangzhou) Co., Ltd. (688075.SS)
About Assure Tech (Hangzhou) Co., Ltd.
Assure Tech (Hangzhou) Co., Ltd engages in the research, development, production, and sale of diagnostic reagents, POCT meters, test readers, and biological materials. The company was founded in 2008 and is based in Hangzhou, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 503.36M | 6.17B | 1.59B | 1.20B | 209.80M | 163.73M | 111.00M |
| Cost of Revenue | 290.45M | 1.55B | 549.18M | 289.01M | 102.29M | 80.90M | 52.73M |
| Gross Profit | 212.91M | 4.61B | 1.04B | 910.75M | 107.51M | 82.83M | 58.27M |
| Gross Profit Ratio | 42.30% | 74.78% | 65.44% | 75.91% | 51.24% | 50.59% | 52.49% |
| Research & Development | 105.27M | 329.07M | 70.38M | 58.45M | 16.19M | 12.15M | 7.87M |
| General & Administrative | 18.75M | 32.79M | 12.53M | 6.59M | 5.33M | 7.03M | 35.94M |
| Selling & Marketing | 42.83M | 493.76M | 30.85M | 22.70M | 12.65M | 11.08M | 5.97M |
| SG&A | 61.59M | 526.55M | 43.38M | 29.29M | 17.98M | 18.11M | 41.91M |
| Other Expenses | -121.44M | 58.30M | 24.51M | 15.79M | 9.85M | 9.18K | -2.21K |
| Operating Expenses | 36.28M | 913.93M | 138.27M | 103.52M | 44.02M | 40.74M | 57.06M |
| Cost & Expenses | 335.87M | 2.47B | 687.45M | 392.53M | 146.32M | 121.64M | 109.79M |
| Interest Income | 14.56M | 24.70M | 1.82M | 201.37K | 92.35K | 25.29K | 171.57K |
| Interest Expense | 1.35M | 2.03M | 142.44K | 32.71K | 125.19K | 320.16K | 464.59K |
| Depreciation & Amortization | 72.11M | 51.24M | 13.28M | 4.07M | 3.60M | 3.19M | 2.23M |
| EBITDA | 217.60M | 3.57B | 878.45M | 778.97M | 66.57M | 44.78M | 248.42K |
| EBITDA Ratio | 43.23% | 70.19% | 56.78% | 64.93% | 32.75% | 28.49% | 1.89% |
| Operating Income | 167.48M | 3.53B | 865.07M | 761.82M | 62.30M | 41.06M | -3.43M |
| Operating Income Ratio | 33.27% | 57.23% | 54.43% | 63.50% | 29.70% | 25.08% | -3.09% |
| Total Other Income/Expenses | -23.67M | -9.33M | -453.42K | -382.69K | -9.55K | 9.18K | -2.21K |
| Income Before Tax | 143.82M | 3.52B | 864.62M | 761.44M | 62.29M | 41.07M | -3.43M |
| Income Before Tax Ratio | 28.57% | 57.08% | 54.40% | 63.47% | 29.69% | 25.08% | -3.09% |
| Income Tax Expense | 2.85M | 475.34M | 126.09M | 112.45M | 7.85M | 7.66M | 2.36M |
| Net Income | 141.55M | 3.04B | 738.53M | 648.99M | 54.47M | 33.37M | -5.86M |
| Net Income Ratio | 28.12% | 49.38% | 46.47% | 54.09% | 25.96% | 20.38% | -5.28% |
| EPS | 1.11 | 23.96 | 5.81 | 5.11 | 0.43 | 0.64 | -0.12 |
| EPS Diluted | 1.11 | 23.96 | 5.81 | 5.11 | 0.43 | 0.64 | -0.12 |
| Weighted Avg Shares Out | 127.53M | 127.08M | 127.08M | 127.08M | 127.08M | 52.38M | 48.59M |
| Weighted Avg Shares Out (Dil) | 127.53M | 127.08M | 127.08M | 127.08M | 127.08M | 52.38M | 48.61M |
No news found for: 688075.SS
Source: https://incomestatements.info
Category: Stock Reports